Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study

Annals of Oncology

Volumn 12, Issue 7, 2001, Pages 957-962

  Quoix, E ^a   Breton, J L ^a   Daniel, C ^a   Jacoulet, P ^a   Debieuvre, D ^a   Paillot, N ^a   Kessler, R ^a   Moreau, L ^a   Coetmeur D ^a   Lemarie E ^a   Milleron, B ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Carboplatin; Chemotherapy; Comorbidity; Elderly; Etoposide phosphate; Small cell lung cancer

Indexed keywords

CARBOPLATIN; ETOPOFOS;

AGE; AGED; ARTICLE; BACTEREMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; ELDERLY CARE; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; KIDNEY DISEASE; LIVER DISEASE; LUNG SMALL CELL CANCER; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROBABILITY; TREATMENT OUTCOME;

EID: 0034899003     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011171722175     Document Type: Article

References (27)

1. Cancer in elderly patients: The population based indexes in Europe (incidence, mortality, survival and prevalence)
2. Etoposide in the treatment of elderly/poor-prognosis patients with small-cell lung cancer
3. Treatment of small-cell lung carcinoma in the elderly
4. Influence of age in efficiency and tolerance of chemotherapy in small-cell lung cancer
5. Influence of age on the treatment of limited-stage-disease small-cell lung cancer
6. Age and the treatment of lung cancer
7. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
8. Carboplatin: A very active new cisplatin analogue in the treatment of small-cell lung cancer
9. VP 16 and carboplatin in previously untreated patients with extensive small-cell lung cancer
10. Oral etoposide and carboplatin. Effective therapy for elderly patients with small-cell lung cancer
11. Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer
12. Cisplatin-etoposide vs. carboplatin-etoposide chemotherapy and irradiation in small-cell lung cancer: A randomized phase III study
13. A phase II study of oral etoposide in elderly patients with small-cell lung cancer
14. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: A stopped multicentre randomised trial
15. Five-day oral etoposide treatment for advanced small-cell lung cancer: Randomized comparison with intravenous chemotherapy
16. Small-cell lung cancer in the elderly patient
17. New combination of the old drugs for elderly patients with small-cell lung cancer: A phase II study of the PAVE regimen
18. Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3 and 5
19. Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3 and 5 in patients with solid tumors
20. Effects of gender, age and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients
21. Treatment of small-cell lung cancer in the elderly
22. An analysis of the outcomes of treatment of small-cell lung cancer in the elderly
23. Vasospastic angina after chemotherapy with carboplatin and etoposide in a patient with lung cancer
24. A phase I trial of continuous infusion VP16-213 (Etoposide)
25. Comorbidity and functional status are independent in older cancer patients
26. Patients at risk of chemotherapy-associated toxicity in small-cell lung cancer